Vitamin B6-dependent epilepsy disorders 1
|
ALDH7A1
| Pyridoxine-dependent epilepsy – ALDH7A1 (PDE-ALDH7A1) 2 | AR | ↑ levels of α-AASA irrespective of treatment w/PN or PLP May also have ↑ levels of pipecolic acid Low PLP levels in plasma & CSF prior to vitamin B6 supplementation
| Szs in affected children respond to supraphysiologic doses of PN (or PLP). | Although most newborns have szs soon after birth, some have late-onset szs (i.e., age >2 mos or as late as adolescence). ID is common, w/more favorable outcomes observed in those w/late-onset szs.
|
PNPO
|
PNPO deficiency
| AR | ↓ CSF & plasma levels of PLP when measured prior to administration of PN or PLP ↑ CSF glycine ↑ urinary vanillactic acid. 3 ↑ plasma PM, ↑ PM:PA ratio. 4
| Szs respond to supraphysiologic doses of PLP (~60% of affected persons) or PN (~40% of affected persons). | The vast majority of infants w/classic PNPO deficiency have szs before age 2 wks, w/30% presenting on day 1 of life. As w/other forms of vitamin B6-dependent epilepsy, if untreated, PNPO deficiency is usually fatal. Motor delay has been reported, likely due to long periods of poor sz control before introduction of PLP/PN treatment. 5
|
Vitamin B6-responsive seizures 6
|
ALDH4A1
| Hyperprolinaemia type II | AR | Markedly ↑ plasma proline levels as well as ↑ P5C in urine |
| Szs usually manifest after neonatal period, may occur w/febrile infections, & may respond to common ASMs. Persons may have ID or normal intellectual ability.
|
ALPL
| Infantile hypophosphatasia (See Hypophosphatasia.) | AR 7 | Using appropriate pediatric normative reference values, this disorder is suspected w/low serum ALP enzyme activity. | Vitamin B6-responsive szs may occur. | Clinical signs may be recognized between birth & age 6 mos & resemble rickets. Prior to availability of enzyme replacement therapy, ~50% succumbed to respiratory failure caused by undermineralization of ribs. Intractable szs may precede biochemical or radiographic manifestations of rickets.
|
CACNA1A
| Developmental & epileptic encephalopathy 42 (OMIM 617106) | AD | No assoc biochemical abnormalities | A female w/CACNA1A-related absence epilepsy & ataxia responded dramatically to PN. 8 | |
GOT2
| Developmental & epileptic encephalopathy 82 (OMIM 618721) | AR | ↑ serum lactate & ammonia | Combined PN & serine resulted in clinical improvement & amelioration of sz frequency. | Early-onset metabolic epileptic encephalopathy Severely impaired intellectual development w/absent speech & spastic tetraplegia Microcephaly, cerebral atrophy, thin corpus callosum, cerebellar hypoplasia, & white matter abnormalities. 9
|
KCNQ2
|
KCNQ2-related disorders
| AD | No assoc biochemical abnormalities | Some persons w/neonatal epilepsy are vitamin B6-responsive. 10 |
|
MOCS2
| MOSC2-related molybdenum cofactor deficiency | AR | When present, ↑ α-AASA is secondary to ALDH7A1 inhibition by accumulated sulfocysteine. | A clear but transient response of szs to PN has been observed in 2 affected sibs. 11 | |
PGAP3
| Hyperphosphatasia w/ID syndrome 4 (OMIM 615716) | AR | ↑ serum ALP | Szs may respond to PN. | DD, ID, structural brain anomalies, dysmorphic facies, & szs |
PIGA
| Multiple congenital anomalies-hypotonia-seizures syndrome 2 4 (OMIM 300868) | XL | ↑ serum ALP in some persons | Heterogeneous effect of PN on szs | Dysmorphic features, hypotonia, early-onset myoclonic seizures, & variable congenital anomalies |
PIGL
| CHIME syndrome (OMIM 280000) | AR | ↑ serum ALP | Szs may respond to PN (but much more slowly than in PDE-ALDH7A1). | Coloboma, congenital heart disease, ichthyosiform dermatosis, ID, & ear anomalies |
PIGO
| Hyperphosphatasia w/ID syndrome 2 (OMIM 614749) | AR | ↑ serum ALP | Szs w/variable response to PN | Moderate-to-severe DD, facial dysmorphism, & brachytelephalangy ± szs |
PIGS
| Developmental & epileptic encephalopathy 95 (OMIM 618143) | AR | Normal serum ALP (except mildly ↑ in 1 person) | Szs may be PN responsive. | Severe DD, ataxia, hypotonia, coarse facies, & intractable szs |
PIGV
| Hyperphosphatasia w/ID syndrome 1 (OMIM 239300) | AR | ↑ serum ALP | Variable neurologic features incl szs that are ± PN responsive. | Distinct facial phenotype, DD, & brachytelephalangy ± anorectal malformations |